Microcirculatory hemodynamics of the rat cremaster muscle flap in reduced blood flow states.
Recent studies revealed that muscle and musculocutaneous flaps have the lowest peripheral resistance and best flap survival. The critical values of flow rates responsible for this survival have not been established. The authors evaluated the effect of prolonged arterial flow reduction on flow hemodynamics and muscle flap survival, independent of neovascularization using the rat cremaster muscle island flap model for microcirculatory studies. Muscle flaps were implanted into a transparent Plexiglas chamber to allow prolonged observation of the microcirculation. Twenty-six male Sprague-Dawley rats were studied in three experimental groups. In group I (control; no occlusion), after flap isolation, the cremaster muscle was implanted into the tissue chamber and microcirculatory measurements were performed from day 0 to day 3. In group II, after flap isolation, flow in the main feeding artery (the iliac) was reduced with a silk suture loop between 47% and 62%. In group III, arterial flow was reduced between 63% and 80%. Vessel diameters, red blood cell velocities, number of perfused capillaries, and number of rolling, sticking, and transmigrating leukocytes were reduced daily for each rat. Immediately after flow reduction, mean arteriolar (A1) diameters were significantly smaller in group II (25%) and group III (29%) compared with the controls (p<0.05). This reduction was confirmed by a drop in red blood cell velocities of 37% and 58% in groups II and III respectively (p<0.05). At day 1, more than 60% of group III flaps had no arterial flow, whereas normal flow was observed in control flaps for as long as 3 days. In addition, the number of perfused capillaries dropped significantly (by 42%) in group II flaps after 3 days (p<0.05). The authors conclude that continuous arterial blood flow reduction exceeding 60% of the normal volume, independent of angiogenesis, is incompatible with flap viability in the rat cremaster muscle model.